A Phase I Trial of Isolated Hepatic Perfusion With Oxaliplatin Followed by Hepatic Arterial Infusion of FUDR and Leucovorin for Patients With Unresectable Colorectal Liver Metastases.

Trial Profile

A Phase I Trial of Isolated Hepatic Perfusion With Oxaliplatin Followed by Hepatic Arterial Infusion of FUDR and Leucovorin for Patients With Unresectable Colorectal Liver Metastases.

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Jan 2016

At a glance

  • Drugs Oxaliplatin (Primary) ; Floxuridine; Folinic acid
  • Indications Cancer metastases; Colorectal cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 08 Dec 2011 Actual patient number is 10 according to ClinicalTrials.gov
    • 08 Dec 2011 Actual end date (Nov 2011) added as reported by ClinicalTrials.gov.
    • 08 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top